These courses are intended for internal hospital staff.

Activity Description:

Medical professionals including physicians, nurses, pharmacists, therapists and other members of the healthcare team require ongoing education pertaining to the recognition, diagnosis, and treatment of patients with neurologic disorders.  Education related to advancements in research, recognition, diagnostic testing, and medical and surgical management will be provided. Additionally, practical guidance related to diagnostic and treatment approaches will be shared in order to facilitate high quality, evidence-based care to this patient population.  Education will be provided via lectures, case-reviews, and interactive question and answer session.  Each participant will be asked to complete an evaluation of the educational offering.

Target Audience: 

Neurologists, emergency department physicians, neurovascular physicians, hospitalists, neuro-intensivists, neurology residents and fellows, medical students, advanced practice nurses, physician assistants, pharmacists, nurses and emergency medical service providers

Learning Objectives:

1. Understand epidemiology and typical presentation of Myasthenia Gravis. 

2. Discuss the basic synaptic transmission to the neuromuscular junction.

3. Review the pathophysiology of AChR Antibody Myasthenia Gravis.

4. Describe the MuSK complex and how targeted antibodies and lead  Myasthenia gravis. 

5. Compare treatment options between anti-AChR MG and  anti-MuSK MG

Moderator:

Dr. Richard Rodriquez-Brizuela, PGY 3

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.